Trial Profile
Chemoradiation Combined With Panitumumab Followed by Surgery for Patients With Operable Esophageal Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Mar 2013
Price :
$35
*
At a glance
- Drugs Panitumumab (Primary) ; Carboplatin; Paclitaxel
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 23 Mar 2013 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
- 06 Mar 2010 New trial record